Comparing diabetes treatments for people with normal weight
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests two medications—pioglitazone (a pill) and tirzepatide (an injection)—in people with type 2 diabetes who have a normal body weight. It aims to find which treatment works better for this specific group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 70 years old.
- You have type 2 diabetes (or pre-diabetes) and your blood sugar levels (A1c) are between 5.7% and 8%.
- Your body mass index (BMI) is between 19 and 24.9, which is in the normal weight range.
- Your weight has not changed by more than 2 kg (about 4.4 lbs) in the last 3 months.
- You are not currently taking insulin or pioglitazone, and you haven't used pioglitazone before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at differences in body fat to understand why some people develop type 2 diabetes. You may be asked for blood tests and health information to see if your diabetes risk and body fat patterns are linked.
This study looks at adults with prediabetes—specifically abnormal fasting and/or 2-hour blood sugar tests—to see whether a treatment helps improve sugar control. You may also be compared with people who have normal blood sugar (the control group).
This study tests how well adults with overweight or obesity, with or without type 2 diabetes, tolerate switching from their current weight-loss medication (tirzepatide) to a new medicine called zenagamtide. It may help you understand if this new option is easier on your stomach.
This study compares people with type 2 diabetes and higher body weight who meet criteria for metabolic (weight-loss) surgery versus people with mild obesity who do not. It aims to see whether surgery improves diabetes-related outcomes more than usual medical care.
This study compares two diabetes medications, dapagliflozin and empagliflozin, to see which is more effective, safe, and affordable for people with type 2 diabetes and a high body weight. Both medications help lower blood sugar and may also help with weight loss.
This study compares two different two-drug combinations for people recently diagnosed with type 2 diabetes. It aims to find which combination works better to control blood sugar and improve overall health.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.